Eli Lilly Buys Verve Therapeutics
Digest more
Top News
Impacts
Stocks declined Tuesday and oil prices rose as Israel and Iran continued to exchange missile attacks and as hopes for a quick resolution to the conflict faded.These stocks were on the move Tuesday:Sunrun sank 40%,
Sunrun (RUN), Plug Power (PLUG), and Array Technologies (ARRY) plunge after the Senate revealed its revisions to President Trump's tax bill, which included cuts to solar and wind energy tax credits. Eli Lilly (LLY) is set to acquire Verve Therapeutics (VERV),
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Verve Therapeutics VERV in the last three months. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
With acquisition of Verve Therapeutics, Eli Lilly aims to advance next-generation cardiovascular care through one-time gene editing treatments.
Explore more